The latest news on whether Talazoparib has been included in medical insurance in the country

Talazoparib (Talazoparib) has been officially launched in China, and patients can usually purchase it through consultation in large hospital pharmacies. However, it is important to note that this drug has not yet been included in the national medical insurance catalog, so it does not enjoy the medical insurance reimbursement policy. For patients undergoing long-term treatment, this means that all costs need to be borne out of pocket, and the financial pressure is relatively high. Therefore, when formulating treatment plans, doctors often make a comprehensive assessment based on the needs for efficacy and the patient's financial affordability.

In terms of price, the cost of different specifications of talazoparib varies greatly. Domestic 0.25mg30 tablets usually cost about 10,000 to 20,000 yuan, while 1mg30 tablets are priced higher, reaching more than 50,000 yuan per box. Since this drug needs to be taken continuously and for a long time as directed by a doctor, the overall treatment cost is relatively high. Therefore, patients should fully understand the price differences of different specifications before purchasing the drug, and choose the most appropriate dose based on their condition and doctor's recommendations.

Original drugs are also available in overseas channels, including Hong Kong and European versions, but the prices are also higher and are usually not much different from domestic ones. In addition, there is a generic version officially launched in Laos. The latest price of 1mg*30 tablets is about 4,000 yuan, which can significantly reduce the cost of medication. Although generic drugs are consistent with the original drugs in terms of composition and mechanism, when purchasing, be sure to confirm that the channel is reliable and ensure drug quality and storage conditions are compliant to avoid buying counterfeit drugs or drugs of substandard quality.

Generally speaking, if patients consider using talazoparib, they should first obtain accurate supply and medication guidance through formal channels such as hospital pharmacies. If they need to use overseas channels, they must also choose legal suppliers to avoid the risks caused by informal purchasing. At the same time, given that the drug is not covered by medical insurance and has high out-of-pocket costs, it is recommended to evaluate the efficacy benefits and economic burden under the guidance of a doctor and formulate a suitable long-term treatment plan.

Reference materials:https://www.talzenna.com/